Copyright
©The Author(s) 2021.
World J Virol. Sep 25, 2021; 10(5): 275-287
Published online Sep 25, 2021. doi: 10.5501/wjv.v10.i5.275
Published online Sep 25, 2021. doi: 10.5501/wjv.v10.i5.275
Question | Ref. | ||
Suwanwongse and Shabarek[22], 2021 | Kuchay et al[23], 2020 | Yang et al[24], 2020 | |
Were there clear criteria for inclusion in the case series? | Yes | Yes | Yes |
Was the condition measured in a standard, reliable way for all participants included in the case series? | Yes | Yes | Yes |
Were valid methods used for the identification of the condition for all participants included in the case series? | Yes | Yes | Yes |
Did the case series have consecutive inclusion of participants? | No | No | Yes |
Did the case series have complete inclusion of participants? | No | No | Yes |
Was there clear reporting of the demographics of the participants in the study? | Yes | Yes | Yes |
Was there clear reporting of clinical information of the participants? | Yes | Yes | Yes |
Were the outcomes or follow-up results of cases clearly reported? | Yes | Yes | Yes |
Was there clear reporting of the presenting site(s)/clinic(s) demographic information? | No | No | Yes |
Was statistical analysis appropriate? | Unclear | Unclear | Yes |
Overall: (Include/Exclude/Seek Further Info) | Include | Include | Include |
- Citation: Shrestha DB, Budhathoki P, Raut S, Adhikari S, Ghimire P, Thapaliya S, Rabaan AA, Karki BJ. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis. World J Virol 2021; 10(5): 275-287
- URL: https://www.wjgnet.com/2220-3249/full/v10/i5/275.htm
- DOI: https://dx.doi.org/10.5501/wjv.v10.i5.275